Education
About Us
Working with TipRanks
Follow Us
Jacobson Pharma Corporation Limited (HK:2633)
:2633
RESEARCH TOOLSreports
2633 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$1.78
Previous CloseN/A
Volume1.98M
Average Volume (3M)1.11M
Market Cap
HK$3.17B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)11.0
Beta0.21
Next Earnings
Nov 21, 2025EPS EstimateN/A
Next Dividend Ex-Date
Aug 11, 2025Dividend Yield3.89%
Share Statistics
EPS (TTM)0.08
Shares Outstanding2,000,221,000
10 Day Avg. Volume717,256
30 Day Avg. Volume1,111,387
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jacobson Pharma Corporation Limited News
2633 FAQ
What was Jacobson Pharma Corporation Limited’s price range in the past 12 months?
Jacobson Pharma Corporation Limited lowest stock price was HK$0.56 and its highest was HK$1.78 in the past 12 months.
What is Jacobson Pharma Corporation Limited’s market cap?
Jacobson Pharma Corporation Limited’s market cap is HK$3.17B.
When is Jacobson Pharma Corporation Limited’s upcoming earnings report date?
Jacobson Pharma Corporation Limited’s upcoming earnings report date is Nov 21, 2025 which is in 111 days.
How were Jacobson Pharma Corporation Limited’s earnings last quarter?
Jacobson Pharma Corporation Limited released its earnings results on Jun 13, 2025. The company reported HK$0.081 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.081.
Is Jacobson Pharma Corporation Limited overvalued?
According to Wall Street analysts Jacobson Pharma Corporation Limited’s price is currently Overvalued.
Does Jacobson Pharma Corporation Limited pay dividends?
Jacobson Pharma Corporation Limited pays a Notavailable dividend of HK$0.115 which represents an annual dividend yield of 3.89%. See more information on Jacobson Pharma Corporation Limited dividends here
What is Jacobson Pharma Corporation Limited’s EPS estimate?
Jacobson Pharma Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jacobson Pharma Corporation Limited have?
Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding.
What happened to Jacobson Pharma Corporation Limited’s price movement after its last earnings report?
Jacobson Pharma Corporation Limited reported an EPS of HK$0.081 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.65%.
Which hedge fund is a major shareholder of Jacobson Pharma Corporation Limited?
Currently, no hedge funds are holding shares in HK:2633
Jacobson Pharma Corporation Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
201.44%
12-Months-Change
Fundamentals
Return on Equity
12.47%
Trailing 12-Months
Asset Growth
4.54%
Trailing 12-Months
Company Description
Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited (2633) is a leading pharmaceutical company based in Hong Kong. It operates in the research, development, production, marketing, and sales of generic drugs, proprietary medicines, and health supplements. The company offers a comprehensive portfolio of products, catering to various therapeutic areas including cardiovascular, respiratory, anti-infective, and gastrointestinal, among others. Jacobson Pharma is recognized for its strong market presence in Hong Kong and its expanding footprint in other Asian regions.
Technical Analysis
Golden Throat Holdings Group Co Ltd
―
China Shineway Pharmaceutical Group Limited
―
Dawnrays Pharmaceutical Holdings Ltd.
―
JBM (Healthcare) Ltd.
―
Lee's Pharmaceutical Holdings Limited
―
Ownership Overview
―
Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.93% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---